© 2024 Maine Public
1450 Lisbon St.
Lewiston, ME 04240

Maine Public Membership Department
63 Texas Ave.
Bangor, ME 04401

Portland Office
323 Marginal Way
Portland, ME 04101

Registered 501(c)(3) EIN: 22-3171529
Play Live Radio
Next Up:
0:00 0:00
Available On Air Stations
Scroll down to see all available streams.

Maine Hospitals Participating in Alzheimer's Drug Trial

BANGOR, Maine - Acadia Hospital and Eastern Maine Medical Center are taking part in a clinical study to assess the effectiveness of a new medication for Alzheimer's disease.

The study will evaluate the effects of T-817MA, a medicine made by Toyama Chemical Co., which is also funding the study.  Researchers say the drug has the potential to slow the pace of the disease in those with mild to moderate Alzheimer's.

Cliff Singer, MD, the chief of geriatric neuro-psychiatry at Acadia Hospital and Eastern Maine Medical Center, says Maine residents often leave the state to participate in trials like this.

"We're very proud to be able to bring clinical trial research to a population that doesn't have access to it," Singer says.

To be eligible to participate in the trial, individuals must be between 55 and 85, with mild-to-moderate Alzheimer's. No new Alzheimer's drug has been approved by the FDA since 2003, but researchers are hoping to change that.